Figure 7From: A novel model for Ki67 assessment in breast cancerCumulative Ki67 estimate based on 50 to 400 tumor cells in steps of 10 for the sample (a core biopsy) showing the largest absolute and relative difference between the model-based estimate and an estimate based on the fixed counting of 200 cells. The shaded region is a 99.0% point-wise confidence interval corresponding to the step-wise test procedure.Back to article page